Ann Davies, Christie patient

When Ann thinks back to her breast cancer diagnosis in March 2014, she thinks about how her life changed completely in a single day. The diagnosis was a shock to her – and the next few years just brought more difficulties.

Ann first had chemotherapy and radiotherapy at her local hospital for the breast cancer. Surgery in 2016 brought hope that her cancer was under control.

But unfortunately, a CT scan revealed the cancer had spread to Ann’s right lung. And while she was having surgery to remove the upper lobe of her lung, scans revealed more tumours – in her brain, her kidneys, and her liver.

At this point, Ann said she knew her situation was critical. She was referred to The Christie in 2019 and placed onto a clinical trial involving a new type of immunotherapy.

Ann started monthly treatment, which involved an hour on an IV drip. The immunotherapy trial wasn’t as tiring as some of the other forms of treatment she’d had – and the results were even better.

Over 2 years later, Ann’s treatment is continuing to minimise all her tumours. The treatment is even helping with the brain tumours, which her treatment team hadn’t expected.

Ann’s now able to lead an active, outdoor lifestyle in her hometown near Llangollen in Wales. She spends her time cycling, doing yoga, running a business with her husband and spending time with her 4 children and 2 grandchildren.

“When I first went on the trial, I didn’t think there was any hope – not with tumours in my liver, my kidneys and my brain.”
“The tumours were just shrinking, and I couldn’t believe it. I thought, ‘this is working’.
“I just feel like I’m living, I feel like I can plan ahead.”

  - Ann, Christie patient

Will you bring hope to more people like Ann with world-first clinical trials at The Christie? Donate to our breast cancer trials Christmas wish campaign today and help our experts develop new treatments.